[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01GA01, streptomycin, Streptomycin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[M03AB01, succinylcholine, The therapeutic efficacy of Succinylcholine can be increased when used in combination with Baclofen.]
[A02BX02, sucralfate, Baclofen may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Baclofen may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Baclofen.]
[J01EC01, sulfamethoxazole, The therapeutic efficacy of Sulfamethoxazole can be decreased when used in combination with Baclofen.]
[S01AB02, sulfisoxazole, The therapeutic efficacy of Sulfisoxazole can be decreased when used in combination with Baclofen.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05AL01, sulpiride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sulpiride.]
[N03AX03, sulthiame, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sulthiame.]
[A10BB04, glibornuride, The therapeutic efficacy of Glibornuride can be decreased when used in combination with Baclofen.]
[A10BC01, glymidine, The therapeutic efficacy of Glymidine can be decreased when used in combination with Baclofen.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Tacrine.]
[N05CD07, temazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Temazepam.]
[R03CC03, terbutaline, Baclofen may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Baclofen may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Baclofen may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S01HA03, tetracaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tetracaine.]
[S03AA02, tetracycline, Baclofen may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05AE05, lurasidone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lurasidone.]
[A04AD10, dronabinol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dronabinol.]
[N04BC07, apomorphine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.]
[L04AX02, thalidomide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Baclofen may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thiethylperazine.]
[N05CA19, thiopental, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thiopental.]
[N05AB08, thioproperazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thioproperazine.]
[N05AC02, thioridazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thioridazine.]
[N05AF04, thiothixene, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thiothixene.]
[G04BE06, moxisylyte, Baclofen may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tiapride.]
[B01AC05, ticlopidine, Baclofen may decrease the excretion rate of Ticlopidine which could result in a higher serum level.]
[N02AX01, tilidine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tilidine.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Timolol.]
[P01AB02, tinidazole, Baclofen may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Tobramycin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A10BB05, tolazamide, The therapeutic efficacy of Tolazamide can be decreased when used in combination with Baclofen.]
[M02AX02, tolazoline, The risk or severity of adverse effects can be increased when Baclofen is combined with Tolazoline.]
[V04CA01, tolbutamide, The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Baclofen.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[M03BX04, tolperisone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tolperisone.]
[N02AX02, tramadol, The risk or severity of CNS depression can be increased when Baclofen is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of hypotension can be increased when Baclofen is combined with Tranylcypromine.]
[N06AX05, trazodone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trazodone.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Triamcinolone.]
[C03DB02, triamterene, Triamterene may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05CD05, triazolam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Triazolam.]
[C03AA06, trichlormethiazide, The risk or severity of adverse effects can be increased when Baclofen is combined with Trichlormethiazide.]
[A03AB12, mepenzolate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[A16AX12, trientine, Baclofen may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trifluoperazine.]
[S01AD02, trifluridine, Baclofen may decrease the excretion rate of Trifluridine which could result in a higher serum level.]
[N05AD02, trifluperidol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trifluperidol.]
[N05AA05, triflupromazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[N04AA01, trihexyphenidyl, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[A03AA05, trimebutine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Alimemazine.]
[N03AC02, trimethadione, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trimethadione.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Baclofen is combined with Trimethaphan.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Trimethoprim.]
[N06AA06, trimipramine, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Trimipramine.]
[R06AX07, triprolidine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Triprolidine.]
[A03BB01, butylscopolamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.]
[N06AX02, tryptophan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tryptophan.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Baclofen is combined with Azilsartan medoxomil.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be increased when used in combination with Baclofen.]
[R03DX07, roflumilast, Baclofen may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Baclofen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Baclofen may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The therapeutic efficacy of Linagliptin can be decreased when used in combination with Baclofen.]
[S01AA28, vancomycin, Vancomycin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N03AX21, ezogabine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ezogabine.]
[B01AF01, rivaroxaban, Baclofen may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, Baclofen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N06AX09, viloxazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.]
[C04AX07, vincamine, The risk or severity of adverse effects can be increased when Baclofen is combined with Vincamine.]
[L01CA02, vincristine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Vincristine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[B01AA03, warfarin, Baclofen may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, The risk or severity of adverse effects can be increased when Baclofen is combined with Xipamide.]
[J05AF01, zidovudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Zidovudine.]
[N05AF05, zuclopenthixol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.]
[J05AE02, indinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Indinavir.]
[N03AX14, levetiracetam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Levetiracetam.]
[M05BA05, tiludronic acid, Baclofen may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Baclofen may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Baclofen may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ibandronate.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Baclofen is combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Baclofen may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Baclofen may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[J01DH04, doripenem, Baclofen may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Atenolol.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be increased when used in combination with Baclofen.]
[S01FA01, atropine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[M01CB03, auranofin, Baclofen may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[B03XA04, peginesatide, Baclofen may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Baclofen may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Baclofen may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Baclofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01DF01, aztreonam, Baclofen may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01AA13, fusidic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Fusidic acid.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A08AA11, lorcaserin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lorcaserin.]
[G04BD12, mirabegron, Baclofen may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L02BB04, enzalutamide, Baclofen may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[N05CA04, barbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Barbital.]
[D02BA02, octinoxate, Baclofen may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[S01GA07, brimonidine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brimonidine.]
[N04BD02, rasagiline, The risk or severity of hypotension can be increased when Baclofen is combined with Rasagiline.]
[C08CA13, lercanidipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Lercanidipine.]
[A03FA09, mosapride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mosapride.]
[N06DA02, donepezil, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Donepezil.]
[N03AX22, perampanel, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Perampanel.]
[N02CC03, zolmitriptan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.]
[R06AC06, thonzylamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[V09IX04, fluorodeoxyglucose F18, Baclofen may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Diethyl ether.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Sildenafil.]
[V08CA11, gadofosveset, Baclofen may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Baclofen may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, The therapeutic efficacy of Alogliptin can be decreased when used in combination with Baclofen.]
[A16AX09, glycerol phenylbutyrate, Baclofen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, The risk or severity of adverse effects can be increased when Baclofen is combined with Bendroflumethiazide.]
[L04AX06, pomalidomide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pomalidomide.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05AD07, benperidol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Benperidol.]
[A10BK02, canagliflozin, The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Baclofen.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Baclofen.]
[R02AD01, benzocaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Benzocaine.]
[A10BX05, pramlintide, The therapeutic efficacy of Pramlintide can be decreased when used in combination with Baclofen.]
[L03AA12, ancestim, Baclofen may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N02CC02, naratriptan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Naratriptan.]
[N04AC01, benztropine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[L01EE01, trametinib, Baclofen may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.]
[V09AX05, florbetapir F-18, Baclofen may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Levomilnacipran.]
[C08EA02, bepridil, The risk or severity of adverse effects can be increased when Baclofen is combined with Bepridil.]
[C02KX05, riociguat, The risk or severity of adverse effects can be increased when Baclofen is combined with Riociguat.]
[A10BJ03, lixisenatide, The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Baclofen.]
[C02KX04, macitentan, The risk or severity of adverse effects can be increased when Baclofen is combined with Macitentan.]
[N06AX26, vortioxetine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.]
[G03AC08, etonogestrel, Baclofen may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[N03AF04, eslicarbazepine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine.]
[J05AP08, sofosbuvir, Baclofen may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[N03AG04, vigabatrin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.]
[A10BK01, dapagliflozin, The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Baclofen.]
[C01CA27, droxidopa, Baclofen may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Acebutolol.]
[N05CH03, tasimelteon, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tasimelteon.]
[L04AA32, apremilast, Baclofen may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Baclofen may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Betamethasone.]
[S01ED02, betaxolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Betaxolol.]
[V03AB34, fomepizole, Baclofen may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, The risk or severity of adverse effects can be increased when Baclofen is combined with Bethanidine.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Bezafibrate.]
[A10BJ04, albiglutide, The therapeutic efficacy of Albiglutide can be decreased when used in combination with Baclofen.]
[A03BA03, hyoscyamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[N01AX05, alfaxalone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Alfaxalone.]
[A10BK03, empagliflozin, The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Baclofen.]
[V08AA01, diatrizoic acid, Baclofen may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[D11AA01, glycopyrronium, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[V08AA04, iothalamic acid, Baclofen may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[N05CM19, suvorexant, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05AA04, acepromazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Acepromazine.]
[A10BJ05, dulaglutide, The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Baclofen.]
[A06AH03, naloxegol, The risk or severity of respiratory depression can be increased when Naloxegol is combined with Baclofen.]
[N04AA02, biperiden, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[S03AA06, gentamicin, Gentamicin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[B01AF03, edoxaban, Baclofen may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[N02BE01, acetaminophen, Baclofen may decrease the excretion rate of Acetaminophen which could result in a higher serum level.]
[L01DC01, bleomycin, Baclofen may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[A03AA09, difemerine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A07DA06, eluxadoline, The risk or severity of respiratory depression can be increased when Eluxadoline is combined with Baclofen.]
[N05AX16, brexpiprazole, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brexpiprazole.]
[G02CX02, flibanserin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.]
[N05AX15, cariprazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cariprazine.]
[A10BF01, acarbose, The therapeutic efficacy of Acarbose can be decreased when used in combination with Baclofen.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01EC01, acetazolamide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Baclofen.]
[N05AB07, acetophenazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Acetophenazine.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Acipimox.]
[V03AB37, idarucizumab, Baclofen may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Trabectedin.]
[J05AF13, tenofovir alafenamide, Tenofovir alafenamide may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[L01XG03, ixazomib, Baclofen may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, The risk or severity of adverse effects can be increased when Baclofen is combined with Selexipag.]
[A10BB31, acetohexamide, The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Baclofen.]
[M04AB05, lesinurad, Baclofen may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[N05CA05, aprobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Aprobarbital.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N03AX23, brivaracetam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brivaracetam.]
[N05BA08, bromazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bromazepam.]
[N04BC01, bromocriptine, The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Baclofen.]
[A02AD05, aluminum magnesium silicate, Baclofen may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[A03AX08, alverine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Alverine.]
[R06AB01, brompheniramine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dexbrompheniramine.]
[N06AA19, amineptin, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Amineptine.]
[C08CA01, amlodipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Amlodipine.]
[N06BX11, aniracetam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Aniracetam.]
[C03CA02, bumetanide, Bumetanide may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N01BB01, bupivacaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.]
[C07AA19, bupranolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Bupranolol.]
[N07BC01, buprenorphine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Buspirone.]
[L01XX27, arsenic trioxide, Baclofen may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Baclofen may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[N02AF01, butorphanol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.]
[S01GX07, azelastine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A06AH05, naldemedine, Baclofen may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Baclofen may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, The therapeutic efficacy of Baclofen can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Beclamide.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Baclofen is combined with Benazepril.]
[A10BX06, benfluorex, The therapeutic efficacy of Benfluorex can be decreased when used in combination with Baclofen.]
[S01HA02, benoxinate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.]
[P01CA02, benznidazole, Baclofen may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The risk or severity of hypotension can be increased when Baclofen is combined with Linezolid.]
[J05AF06, abacavir, Baclofen may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Baclofen may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Baclofen.]
[N04BD03, safinamide, The risk or severity of hypotension can be increased when Baclofen is combined with Safinamide.]
[J01MA23, delafloxacin, Baclofen may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Baclofen may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Bisoprolol.]
[J05AG03, efavirenz, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N04AA11, bornaprine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.]
[N05CD09, brotizolam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brotizolam.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Baclofen may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05CA03, butobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Butobarbital.]
[N06AA15, butriptyline, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Butriptyline.]
[A10BJ06, semaglutide, The therapeutic efficacy of Semaglutide can be decreased when used in combination with Baclofen.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Baclofen.]
[N05CA08, butylvinal, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vinylbital.]
[R06AX18, acrivastine, Baclofen may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Baclofen is combined with Captopril.]
[L02BB05, apalutamide, Baclofen may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[A03AA03, camylofine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Carbimazole.]
[R06AA08, carbinoxamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Carbinoxamine.]
[C07AG02, carvedilol, The risk or severity of adverse effects can be increased when Baclofen is combined with Carvedilol.]
[N03AX24, cannabidiol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cannabidiol.]
[L04AA37, baricitinib, Baclofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01GB14, plazomicin, Plazomicin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C07AB08, celiprolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Celiprolol.]
[A16AX14, migalastat, Baclofen may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Stiripentol.]
[S01GX12, cetirizine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cetirizine.]
[N05CM04, carbromal, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Carbromal.]
[A10BB06, carbutamide, The therapeutic efficacy of Carbutamide can be decreased when used in combination with Baclofen.]
[N01BA04, chloroprocaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chloroprocaine.]
[D08AE05, chloroxylenol, Baclofen may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[R06AA06, chlorphenoxamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Baclofen.]
[R03BB08, revefenacin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L01AD01, carmustine, Baclofen may decrease the excretion rate of Carmustine which could result in a higher serum level.]
[A06AX05, prucalopride, Baclofen may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Baclofen is combined with Cilazapril.]
[B01AC23, cilostazol, Baclofen may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[A03FA08, cinitapride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cinitapride.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ciprofibrate.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Baclofen is combined with Esketamine.]
[N06BA14, solriamfetol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Solriamfetol.]
[N06AX29, brexanolone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Brexanolone.]
[N05BA09, clobazam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Clobazam.]
[N05BA22, cloxazolam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cloxazolam.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ubidecarenone.]
[C09CA06, candesartan, The risk or severity of adverse effects can be increased when Baclofen is combined with Candesartan.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05AA06, cyamemazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cyamemazine.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C03BX03, cicletanine, The risk or severity of adverse effects can be increased when Baclofen is combined with Cicletanine.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Baclofen.]
[N07XX11, pitolisant, Baclofen may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[C03AA09, cyclothiazide, The risk or severity of adverse effects can be increased when Baclofen is combined with Cyclothiazide.]
[G04BE04, yohimbine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Baclofen.]
[S01EX02, dapiprazole, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dapiprazole.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Baclofen.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Baclofen.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[M09AX08, golodirsen, Baclofen may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[R06AB06, dexbrompheniramine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dexbrompheniramine.]
[S01XA12, dexpanthenol, Baclofen may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N02AX03, dezocine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dezocine.]
[N05CM21, lemborexant, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lemborexant.]
[N05AD10, lumateperone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lumateperone.]
[N02CC07, frovatriptan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Frovatriptan.]
[N05CC04, dichloralphenazone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dichloralphenazone.]
[R02AA03, dichlorobenzyl alcohol, Baclofen may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Baclofen may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[A07DA04, difenoxin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Difenoxin.]
[N02AA08, dihydrocodeine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dihydrocodeine.]
[N02CC06, eletriptan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Eletriptan.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C08CA16, clevidipine, Baclofen may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[N03AG02, dipropylacetamide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Valpromide.]
[N05BA02, chlordiazepoxide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide.]
[C02AA06, methoserpidine, The risk or severity of adverse effects can be increased when Baclofen is combined with Methoserpidine.]
[A03AA08, dihexyverine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[G04BD09, trospium, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[V08CA05, mangafodipir, Baclofen may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05CM02, chlormethiazole, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.]
[M03BB02, chlormezanone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlormezanone.]
[R02AD04, dyclonine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dyclonine.]
[C08CA17, levamlodipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Levamlodipine.]
[N05CD14, remimazolam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Remimazolam.]
[N07XX04, sodium oxybate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Baclofen is combined with Oliceridine.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Chloroquine.]
[C03AA04, chlorothiazide, The risk or severity of adverse effects can be increased when Baclofen is combined with Chlorothiazide.]
[D01AE07, chlorphenesin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlorphenesin.]
[R06AB04, chlorpheniramine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlorpheniramine.]
[N05AA01, chlorpromazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.]
[A10BB02, chlorpropamide, The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Baclofen.]
[N05AF03, chlorprothixene, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, The risk or severity of adverse effects can be increased when Baclofen is combined with Chlorthalidone.]
[M03BB03, chlorzoxazone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.]
[N05BX03, etifoxine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Etifoxine.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N02BA03, choline salicylate, Baclofen may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[N06BX18, vinpocetine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vinpocetine.]
[N05BA18, ethyl loflazepate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethyl loflazepate.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Etofibrate.]
[M01AX25, chondroitin sulfates, Baclofen may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[M03BA05, febarbamate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Febarbamate.]
[N03AX10, felbamate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Felbamate.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be increased when Baclofen is combined with Fenoldopam.]
[J01DD15, cefdinir, Baclofen may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Baclofen may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[N02BG07, flupirtine, Baclofen may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Baclofen.]
[N01AB05, trichloroethylene, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trichloroethylene.]
[H04AA02, dasiglucagon, The risk or severity of adverse effects can be increased when Baclofen is combined with Dasiglucagon.]
[A02BA01, cimetidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Cimetidine.]
[N02BF01, gabapentin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.]
[V08CA04, gadoteridol, Baclofen may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[S03AA07, ciprofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ciprofloxacin.]
[L01XA01, cisplatin, Cisplatin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N06AB04, citalopram, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Citalopram.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[V09AB03, ioflupane I-123, Baclofen may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Baclofen may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Baclofen may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[R06AA04, clemastine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Clemastine.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A10BB12, glimepiride, The therapeutic efficacy of Glimepiride can be decreased when used in combination with Baclofen.]
[A10BB08, gliquidone, The therapeutic efficacy of Gliquidone can be decreased when used in combination with Baclofen.]
[N06AX25, St. John's wort extract, Baclofen may increase the central nervous system depressant (CNS depressant) activities of St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Baclofen.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Clofibrate.]
[N01BB10, levobupivacaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Levobupivacaine.]
[N06AA04, clomipramine, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Clomipramine.]
[N03AE01, clonazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Baclofen.]
[J05AH02, oseltamivir, Baclofen may decrease the excretion rate of Oseltamivir which could result in a higher serum level.]
[A10BX16, tirzepatide, The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Baclofen.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH06, clothiapine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Clothiapine.]
[N05BA21, clotiazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Clotiazepam.]
[A04AA01, ondansetron, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.]
[A04AA02, granisetron, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Granisetron.]
[N05AH02, clozapine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Clozapine.]
[A10BX01, guar gum, The therapeutic efficacy of Guar gum can be decreased when used in combination with Baclofen.]
[A10BK06, sotagliflozin, The therapeutic efficacy of Sotagliflozin can be decreased when used in combination with Baclofen.]
[J01GB12, arbekacin, Arbekacin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05BA13, halazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Halazepam.]
[S02DA02, cocaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02KB01, metyrosine, The risk or severity of adverse effects can be increased when Baclofen is combined with Metyrosine.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[R05DA04, codeine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Codeine.]
[M03AC05, hexafluorenium, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Colchicine.]
[A03AB10, hexocyclium, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[J01XB01, colistin, Colistin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Leflunomide.]
[N01AB07, desflurane, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Desflurane.]
[A04AA03, tropisetron, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tropisetron.]
[C04AX28, ifenprodil, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ifenprodil.]
[A10BX03, nateglinide, The therapeutic efficacy of Nateglinide can be decreased when used in combination with Baclofen.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[H01AC03, mecasermin, The therapeutic efficacy of Mecasermin can be decreased when used in combination with Baclofen.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Baclofen.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[R06AX27, desloratadine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Desloratadine.]
[J05AB14, valganciclovir, Baclofen may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Baclofen may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Baclofen may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Baclofen may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Baclofen may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Baclofen may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N02CC05, almotriptan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05BA10, ketazolam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C08CA09, lacidipine, Baclofen may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[S01GX02, levocabastine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Levocabastine.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Nafarelin.]
[N07BC04, lofexidine, The therapeutic efficacy of Baclofen can be increased when used in combination with Lofexidine.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05CD06, lormetazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lormetazepam.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Baclofen is combined with Lisinopril.]
[A06AD01, magnesium carbonate, Baclofen may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Manidipine.]
[A03AA04, mebeverine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Medifoxamine.]
[J01DH02, meropenem, Baclofen may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[N04AA03, methixene, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R06AE03, cyclizine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cyclizine.]
[N05CA10, cyclobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cyclobarbital.]
[C03DA04, eplerenone, The risk or severity of adverse effects can be increased when Baclofen is combined with Eplerenone.]
[N05AD03, metylperon, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Melperone.]
[C03AA07, cyclopenthiazide, The risk or severity of adverse effects can be increased when Baclofen is combined with Cyclopenthiazide.]
[A10BF02, miglitol, The therapeutic efficacy of Miglitol can be decreased when used in combination with Baclofen.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N06AX07, minaprine, The risk or severity of hypotension can be increased when Baclofen is combined with Minaprine.]
[S01XA18, cyclosporine, Cyclosporine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N06AG02, moclobemide, The risk or severity of hypotension can be increased when Baclofen is combined with Moclobemide.]
[R06AX02, cyproheptadine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C09AA13, moexipril, The risk or severity of adverse effects can be increased when Baclofen is combined with Moexipril.]
[C10AA07, rosuvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Rosuvastatin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AC05, moxonidine, The risk or severity of adverse effects can be increased when Baclofen is combined with Moxonidine.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Cytarabine.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[L01AX04, dacarbazine, Baclofen may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M03CA01, dantrolene, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dantrolene.]
[N06BX04, deanol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Deanol.]
[C02CC04, debrisoquin, The risk or severity of adverse effects can be increased when Baclofen is combined with Debrisoquine.]
[A04AD11, nabilone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Nabilone.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N07BB05, nalmefene, Baclofen may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[N05BA16, nordazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Nordazepam.]
[C07AB12, nebivolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Nebivolol.]
[S01GX04, nedocromil, Baclofen may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Nefazodone.]
[N05CM16, niaprazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Niaprazine.]
[C01DX16, nicorandil, The risk or severity of adverse effects can be increased when Baclofen is combined with Nicorandil.]
[L02BB02, nilutamide, Baclofen may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[N03AG06, tiagabine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tiagabine.]
[M03AC11, cisatracurium, The therapeutic efficacy of Cisatracurium can be increased when used in combination with Baclofen.]
[R05DA06, normethadone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Normethadone.]
[B01AX05, fondaparinux, Baclofen may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[N06AB10, escitalopram, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Escitalopram.]
[G04BD08, solifenacin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N06AA01, desipramine, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Desipramine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[V04CH02, indigo carmine, Baclofen may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Baclofen may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[C09XA02, aliskiren, The risk or severity of adverse effects can be increased when Baclofen is combined with Aliskiren.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N03AF02, oxcarbazepine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.]
[S03BA01, dexamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Dexamethasone.]
[N06BX07, oxiracetam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxiracetam.]
[N04AA08, dexetimide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A03AA01, oxyphencyclimine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[N06BA02, dextroamphetamine, Baclofen may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[R05DA09, dextromethorphan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dextromethorphan.]
[N03AC01, paramethadione, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Paramethadione.]
[N02AC01, dextromoramide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dextromoramide.]
[N06AB05, paroxetine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Paroxetine.]
[N07BC06, heroin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Diamorphine.]
[C01DA05, pentaerythritol tetranitrate, Baclofen may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Baclofen may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Diazepam.]
[N03AX07, phenacemide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Phenacemide.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Baclofen is combined with Diazoxide.]
[N03AD02, phensuximide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Dibenzepin.]
[S02DA04, dibucaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cinchocaine.]
[R05DA08, pholcodine, Baclofen may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A03AA07, dicyclomine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[J05AF02, didanosine, Baclofen may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, The risk or severity of adverse effects can be increased when Baclofen is combined with Pinacidil.]
[A10BG03, pioglitazone, The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Baclofen.]
[N05AD05, pipamperone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pipamperone.]
[A03AB14, pipenzolate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Diethylpropion.]
[C08CA03, isradipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Isradipine.]
[D07XC04, diflucortolone, Baclofen may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[A03AB11, poldine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C01AA05, digoxin, Baclofen may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C02DB01, dihydralazine, The risk or severity of adverse effects can be increased when Baclofen is combined with Dihydralazine.]
[N02CA01, dihydroergotamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dihydroergotamine.]
[N02AA03, hydromorphone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.]
[L04AX04, lenalidomide, Baclofen may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[B01AC21, treprostinil, The risk or severity of adverse effects can be increased when Baclofen is combined with Treprostinil.]
[H03BC01, potassium perchlorate, Baclofen may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Baclofen may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pramocaine.]
[C08DB01, diltiazem, The risk or severity of adverse effects can be increased when Baclofen is combined with Diltiazem.]
[R06AA11, dimenhydrinate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dimenhydrinate.]
[V03AB09, dimercaprol, Baclofen may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M03BX03, pridinol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pridinol.]
[R06AB03, dimethindene, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[M02AX03, dimethyl sulfoxide, Baclofen may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N03AG05, progabide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Progabide.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01HA04, proparacaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Proparacaine.]
[R06AA02, diphenhydramine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.]
[A07DA01, diphenoxylate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Diphenoxylate.]
[N05CD10, quazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Quazepam.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Baclofen is combined with Quinapril.]
[N06BA11, dexmethylphenidate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dexmethylphenidate.]
[N06AA23, quinupramine, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Quinupramine.]
[A03FA02, cisapride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cisapride.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Baclofen is combined with Ramipril.]
[N05AL04, remoxipride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Remoxipride.]
[S01AX06, resorcinol, Baclofen may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The therapeutic efficacy of Disopyramide can be decreased when used in combination with Baclofen.]
[N07XX02, riluzole, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Riluzole.]
[N05AX08, risperidone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Risperidone.]
[R06AE09, levocetirizine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.]
[N01BB09, ropivacaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ropivacaine.]
[L01EX01, sunitinib, The therapeutic efficacy of Sunitinib can be decreased when used in combination with Baclofen.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, The risk or severity of adverse effects can be increased when Baclofen is combined with Tadalafil.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C02KX02, ambrisentan, The risk or severity of adverse effects can be increased when Baclofen is combined with Ambrisentan.]
[C01EB18, ranolazine, Baclofen may decrease the excretion rate of Ranolazine which could result in a higher serum level.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C01CA07, dobutamine, Baclofen may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Baclofen may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA16, dothiepin, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Dosulepin.]
[N06AA12, doxepin, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Doxepin.]
[J01AA02, doxycycline, Baclofen may decrease the excretion rate of Doxycycline which could result in a higher serum level.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Baclofen.]
[N06AB06, sertraline, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sertraline.]
[N01AB08, sevoflurane, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sevoflurane.]
[N05AD08, droperidol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Droperidol.]
[A08AA10, sibutramine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sibutramine.]
[C10AA01, simvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Simvastatin.]
[A12CA02, sodium sulfate, Baclofen may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[C09AA11, spirapril, The risk or severity of adverse effects can be increased when Baclofen is combined with Spirapril.]
[R03DA01, dyphylline, Baclofen may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N05AL02, sultopride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sultopride.]
[N02CC01, sumatriptan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sumatriptan.]
[V04CX07, edrophonium, Baclofen may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Talinolol.]
[L01AX03, temozolomide, Baclofen may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[G04CA03, terazosin, The risk or severity of adverse effects can be increased when Baclofen is combined with Terazosin.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Terbinafine.]
[M03BX07, tetrazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tetrazepam.]
[M03BX05, thiocolchicoside, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thiocolchicoside.]
[N05AB05, thiopropazate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thiopropazate.]
[G04BD01, emepronium, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Tianeptine.]
[C09AA02, enalapril, The risk or severity of adverse effects can be increased when Baclofen is combined with Enalapril.]
[N05BA23, tofisopam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tofisopam.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N06AG03, toloxatone, The risk or severity of hypotension can be increased when Baclofen is combined with Toloxatone.]
[N06BA09, atomoxetine, Baclofen may decrease the excretion rate of Atomoxetine which could result in a higher serum level.]
[N03AX11, topiramate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Topiramate.]
[C03CA04, torsemide, The risk or severity of adverse effects can be increased when Baclofen is combined with Torasemide.]
[C09AA10, trandolapril, The risk or severity of adverse effects can be increased when Baclofen is combined with Trandolapril.]
[N05CD11, triazulenone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Loprazolam.]
[N05CC01, chloral hydrate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chloral hydrate.]
[N05CM07, triclofos, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Triclofos.]
[A03AB08, tridihexethyl, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Trimethobenzamide.]
[N04AA12, tropatepine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Enflurane.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Baclofen is combined with Urapidil.]
[N05AL06, veralipride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Veralipride.]
[S01GX10, epinastine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Epinastine.]
[N06AX16, venlafaxine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.]
[C09AA15, zofenopril, The risk or severity of adverse effects can be increased when Baclofen is combined with Zofenopril.]
[N05CF02, zolpidem, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N03AX15, zonisamide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Baclofen.]
[N05CF01, zopiclone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[N05AX11, zotepine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zotepine.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Baclofen is combined with Guanfacine.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Iloprost.]
[C01BG01, moricizine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Moricizine.]
[G02AB03, ergonovine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ergometrine.]
[C04AE01, ergoloid mesylates, USP, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ergoloid mesylate.]
[N02CA02, ergotamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ergotamine.]
[L03AX05, pidotimod, Baclofen may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Estazolam.]
[A02BC02, pantoprazole, Baclofen may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[G03CA03, estradiol, Baclofen may decrease the excretion rate of Estradiol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Baclofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[J04AK02, ethambutol, Baclofen may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[C10AA04, fluvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Fluvastatin.]
[V08CA03, gadodiamide, Baclofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.]
[N05CM08, ethchlorvynol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethchlorvynol.]
[C01BD05, ibutilide, Baclofen may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[N04AA05, profenamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethosuximide.]
[N03AB01, ethotoin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethotoin.]
[N01BX01, ethyl chloride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethyl chloride.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01XA06, ethylmorphine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethylmorphine.]
[N01AX07, etomidate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Etomidate.]
[N05AE03, sertindole, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sertindole.]
[L04AD02, tacrolimus, Tacrolimus may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Nizatidine.]
[R06AX12, terfenadine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.]
[P01AX07, trimetrexate, Baclofen may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bupropion.]
[N06AB08, fluvoxamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fluvoxamine.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Baclofen.]
[C10AA03, pravastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Baclofen.]
[M01CB01, gold sodium thiomalate, Baclofen may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Baclofen may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Baclofen may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A16AA01, levocarnitine, Baclofen may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[C08CA02, felodipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Felodipine.]
[N03AX26, fenfluramine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N02AB03, fentanyl, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fentanyl.]
[R03CC02, albuterol, Baclofen may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, Baclofen may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Cladribine.]
[N07AX03, cevimeline, Baclofen may decrease the excretion rate of Cevimeline which could result in a higher serum level.]
[G04BD02, flavoxate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J02AC01, fluconazole, Baclofen may decrease the excretion rate of Fluconazole which could result in a higher serum level.]
[J02AX01, flucytosine, Baclofen may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Baclofen may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.]
[N05CD03, flunitrazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Flunitrazepam.]
[N06AA14, melitracen, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Melitracen.]
[V03AZ01, ethanol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, Baclofen may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[N06AB03, fluoxetine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.]
[N05AF01, flupenthixol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.]
[N05CD01, flurazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Flurazepam.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05AG01, fluspirilene, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fluspirilene.]
[L02BB01, flutamide, Baclofen may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S02AA17, fosfomycin, Baclofen may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[L01BC03, tegafur, Baclofen may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be increased when used in combination with Baclofen.]
[G01AX06, furazolidone, The risk or severity of hypotension can be increased when Baclofen is combined with Furazolidone.]
[C03CA01, furosemide, The risk or severity of adverse effects can be increased when Baclofen is combined with Furosemide.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Alendronic acid.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Baclofen is combined with Eszopiclone.]
[N05AL05, amisulpride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Amisulpride.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be increased when used in combination with Baclofen.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ganciclovir.]
[N03AA04, barbexaclone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Barbexaclone.]
[N06AX08, bifemelane, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Bifemelane.]
[C10AB04, gemfibrozil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Gemfibrozil.]
[J01XA03, telavancin, Baclofen may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04BC06, cabergoline, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Cabergoline.]
[A10BJ02, liraglutide, The therapeutic efficacy of Liraglutide can be decreased when used in combination with Baclofen.]
[N03AD03, methsuximide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methsuximide.]
[N01AH02, alfentanil, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Alfentanil.]
[A10BB01, glyburide, The therapeutic efficacy of Glyburide can be decreased when used in combination with Baclofen.]
[A10BB09, gliclazide, The therapeutic efficacy of Gliclazide can be decreased when used in combination with Baclofen.]
[A10BB07, glipizide, The therapeutic efficacy of Glipizide can be decreased when used in combination with Baclofen.]
[N05CM18, dexmedetomidine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dexmedetomidine.]
[N05CE01, glutethimide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.]
[C05AE01, nitroglycerin, The risk or severity of adverse effects can be increased when Baclofen is combined with Nitroglycerin.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Baclofen is combined with Doxazosin.]
[L01EX02, sorafenib, Baclofen may decrease the excretion rate of Sorafenib which could result in a higher serum level.]
[C07AB09, esmolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Esmolol.]
[M01CB04, aurothioglucose, Baclofen may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Baclofen may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Baclofen is combined with Fosinopril.]
[S01EX01, guanethidine, The risk or severity of adverse effects can be increased when Baclofen is combined with Guanethidine.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Baclofen.]
[N01AB01, halothane, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Halothane.]
[N05AH04, quetiapine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.]
[N06BX13, idebenone, Baclofen may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Baclofen.]
[N02CX03, iprazochrome, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Iprazochrome.]
[N05CA21, allobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Allobarbital.]
[M04AA01, allopurinol, Baclofen may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[C09CA01, losartan, The risk or severity of adverse effects can be increased when Baclofen is combined with Losartan.]
[G03DC01, allylestrenol, Baclofen may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C01CE02, milrinone, Baclofen may decrease the excretion rate of Milrinone which could result in a higher serum level.]
[N05CA16, hexobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Hexobarbital.]
[C08CA10, nilvadipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Baclofen is combined with Perindopril.]
[C02DB02, hydralazine, The risk or severity of adverse effects can be increased when Baclofen is combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of adverse effects can be increased when Baclofen is combined with Hydrochlorothiazide.]
[R05DA03, hydrocodone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, The risk or severity of adverse effects can be increased when Baclofen is combined with Hydroflumethiazide.]
[B05XA17, potassium acetate, Baclofen may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Baclofen may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.]
[G04BD06, propiverine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[N05AX07, prothipendyl, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Prothipendyl.]
[B05AA07, hetastarch, Baclofen may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Baclofen.]
[C02AC06, rilmenidine, The risk or severity of adverse effects can be increased when Baclofen is combined with Rilmenidine.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Risedronic acid.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[B05XA08, sodium acetate, Baclofen may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Baclofen may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N01AH03, sufentanil, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Sufentanil.]
[N06AA02, imipramine, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Imipramine.]
[L01CD01, paclitaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Paclitaxel.]
[R01AD07, tixocortol, Baclofen may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tizanidine.]
[L01CE01, topotecan, Baclofen may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, The risk or severity of adverse effects can be increased when Baclofen is combined with Indapamide.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C02CA02, indoramin, The risk or severity of adverse effects can be increased when Baclofen is combined with Indoramin.]
[A11HA07, inositol, Baclofen may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Milnacipran.]
[A03AA30, piperidolate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[S01XA28, varenicline, Baclofen may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Articaine.]
[A10BH01, sitagliptin, The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Baclofen.]
[N05BA12, alprazolam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Alprazolam.]
[N05CH02, ramelteon, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ramelteon.]
[R06AE01, buclizine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[A10BH02, vildagliptin, The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Baclofen.]
[C10AA06, cerivastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Cerivastatin.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Stavudine.]
[N06AA13, iprindole, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Iprindole.]
[N06AF05, iproniazid, The risk or severity of hypotension can be increased when Baclofen is combined with Iproniazid.]
[N05AA07, chlorproethazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of hypotension can be increased when Baclofen is combined with Isocarboxazid.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Baclofen is combined with Imidapril.]
[N01AB06, isoflurane, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Isoflurane.]
[N04BX02, entacapone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Entacapone.]
[J04AC01, isoniazid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Isoniazid.]
[J05AX05, inosine pranobex, Baclofen may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[A10BJ01, exenatide, The therapeutic efficacy of Exenatide can be decreased when used in combination with Baclofen.]
[C01DA14, isosorbide mononitrate, Baclofen may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ivermectin.]
[N06AX18, reboxetine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Reboxetine.]
[S01AA24, kanamycin, Kanamycin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Baclofen.]
[N01AX03, ketamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ketamine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Baclofen is combined with Ketanserin.]
[B01AC22, prasugrel, Baclofen may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[N05AH03, olanzapine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N04BC09, rotigotine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[D10AX03, azelaic acid, Baclofen may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C07AG01, labetalol, The risk or severity of adverse effects can be increased when Baclofen is combined with Labetalol.]
[N04BB01, amantadine, Baclofen may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[C02AA05, deserpidine, The risk or severity of adverse effects can be increased when Baclofen is combined with Deserpidine.]
[A06AX03, lubiprostone, Baclofen may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lacosamide.]
[C03CC01, ethacrynic acid, Etacrynic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N04BA01, levodopa, The therapeutic efficacy of Levodopa can be decreased when used in combination with Baclofen.]
[S02DA01, lidocaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lidocaine.]
[S01AA21, amikacin, Amikacin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lisuride.]
[N06AA07, lofepramine, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Lofepramine.]
[N05BA06, lorazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Lorazepam.]
[C10AA02, lovastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Lovastatin.]
[N05AH01, loxapine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Loxapine.]
[B05XA11, magnesium chloride, Baclofen may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Baclofen may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Baclofen can be increased when used in combination with Magnesium sulfate.]
[L01BA05, pralatrexate, Baclofen may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N06AA21, maprotiline, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mazindol.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Baclofen is combined with Mecamylamine.]
[R06AE05, meclizine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Meclizine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05BA03, medazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Medazepam.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Mefloquine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH01, melatonin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Melatonin.]
[N06DX01, memantine, Baclofen may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Meperidine.]
[M03BX06, mephenesin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mephenesin.]
[N03AB04, mephenytoin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mephenytoin.]
[N03AA01, mephobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methylphenobarbital.]
[N01BB03, mepivacaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mepivacaine.]
[N05BC01, meprobamate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Meprobamate.]
[N02AX05, meptazinol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Meptazinol.]
[G04BX16, tiopronin, Baclofen may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mesoridazine.]
[N05AX13, paliperidone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Paliperidone.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be decreased when used in combination with Baclofen.]
[A04AA04, dolasetron, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dolasetron.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Baclofen.]
[N06BA03, methamphetamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Metamfetamine.]
[A03AB07, methantheline, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methapyrilene.]
[N05CM01, methaqualone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methaqualone.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Lamivudine.]
[N03AA30, metharbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Metharbital.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Metergoline.]
[H03BB02, methimazole, Baclofen may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Baclofen may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[M03BA03, methocarbamol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methocarbamol.]
[N05CA15, methohexital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methohexital.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N02BG08, ziconotide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05AA02, methotrimeprazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[D05BA02, methoxsalen, Baclofen may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[N02BG09, methoxyflurane, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methoxyflurane.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The risk or severity of adverse effects can be increased when Baclofen is combined with Methyldopa.]
[V04CG05, methylene blue, The risk or severity of hypotension can be increased when Baclofen is combined with Methylene blue.]
[N03AF03, rufinamide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Rufinamide.]
[G03EK01, methyltestosterone, Baclofen may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N05CE02, methyprylon, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methyprylon.]
[N02CA04, methysergide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methysergide.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Baclofen.]
[C03BA08, metolazone, The risk or severity of adverse effects can be increased when Baclofen is combined with Metolazone.]
[C07AB02, metoprolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Metoprolol.]
[V04CD01, metyrapone, Baclofen may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N06AX03, mianserin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mianserin.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05CD08, midazolam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Midazolam.]
[G03XB01, mifepristone, The therapeutic efficacy of Mifepristone can be decreased when used in combination with Baclofen.]
[J05AH01, zanamivir, Baclofen may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[C09CA03, valsartan, The risk or severity of adverse effects can be increased when Baclofen is combined with Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Baclofen.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Baclofen is combined with Minoxidil.]
[N05AE02, molindone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Molindone.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C01BD01, amiodarone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Amiodarone.]
[N06AA09, amitriptyline, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Amitriptyline.]
[N02AA01, morphine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Morphine.]
[A04AA05, palonosetron, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Baclofen may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Baclofen may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Baclofen may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be increased when used in combination with Baclofen.]
[N05CA02, amobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Amobarbital.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Raltegravir.]
[R03BB01, ipratropium bromide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[N06AA17, amoxapine, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Amoxapine.]
[N03AB05, fosphenytoin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fosphenytoin.]
[C07AA12, nadolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Nadolol.]
[J01CA04, amoxicillin, Baclofen may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, Baclofen may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Naftidrofuryl.]
[N02AF02, nalbuphine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Nalbuphine.]
[V03AB15, naloxone, Baclofen may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Naltrexone.]
[N06BA01, amphetamine, Baclofen may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A10BG01, troglitazone, The therapeutic efficacy of Troglitazone can be decreased when used in combination with Baclofen.]
[N06AX21, duloxetine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Duloxetine.]
[N04BX01, tolcapone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Tolcapone.]
[L01CD02, docetaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Docetaxel.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Letrozole.]
[S03AA01, neomycin, Neomycin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N01AH06, remifentanil, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Remifentanil.]
[A10BX02, repaglinide, The therapeutic efficacy of Repaglinide can be decreased when used in combination with Baclofen.]
[B01AC17, tirofiban, Baclofen may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[N05AX14, iloperidone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01AA19, ampicillin, Baclofen may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Baclofen may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Netilmicin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Desvenlafaxine.]
[C09CA07, telmisartan, The risk or severity of adverse effects can be increased when Baclofen is combined with Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C01CE01, inamrinone, Baclofen may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Niacin.]
[N06AF02, nialamide, The risk or severity of hypotension can be increased when Baclofen is combined with Nialamide.]
[C08CA04, nicardipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Nicardipine.]
[C08CA05, nifedipine, Baclofen may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C08CA06, nimodipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Nimodipine.]
[C08CA07, nisoldipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Nisoldipine.]
[N05CD02, nitrazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.]
[C08CA08, nitrendipine, The risk or severity of adverse effects can be increased when Baclofen is combined with Nitrendipine.]
[R07AX01, nitric oxide, Baclofen may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Baclofen may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.]
[N04BC05, pramipexole, Baclofen may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, The risk or severity of adverse effects can be increased when Baclofen is combined with Nitroprusside.]
[N01AX13, nitrous oxide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Nitrous oxide.]
[N06AX04, nomifensine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Nomifensine.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Norfloxacin.]
[C02KX01, bosentan, The risk or severity of adverse effects can be increased when Baclofen is combined with Bosentan.]
[N06AA10, nortriptyline, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Nortriptyline.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ofloxacin.]
[N06AA05, opipramol, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Opipramol.]
[N02AA02, opium, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Opium.]
[G04CA02, tamsulosin, Baclofen may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[J01CF04, oxacillin, Baclofen may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Oxprenolol.]
[N02AA05, oxycodone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.]
[N02AA11, oxymorphone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.]
[N05AE01, oxypertine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxypertine.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A03AB03, oxyphenonium, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Baclofen.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be increased when used in combination with Baclofen.]
[J04AB30, capreomycin, Capreomycin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N05CC05, paraldehyde, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Baclofen is combined with Pargyline.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[G04BD11, fesoterodine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Penbutolol.]
[N05AG03, penfluridol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Penfluridol.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Penicillamine.]
[J01CE09, penicillin G procaine, Baclofen may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N02AD01, pentazocine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pentazocine.]
[N05CA01, pentobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pentobarbital.]
[L01XX08, pentostatin, Baclofen may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Baclofen may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N05AB10, perazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Perazine.]
[N04BC02, pergolide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pergolide.]
[N05AB03, perphenazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Perphenazine.]
[N02AD02, phenazocine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Phenazocine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N06AF03, phenelzine, The risk or severity of hypotension can be increased when Baclofen is combined with Phenelzine.]
[A10BA01, phenformin, The therapeutic efficacy of Phenformin can be decreased when used in combination with Baclofen.]
[N03AA02, phenobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Phenobarbital.]
[N01AH04, phenoperidine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Phenoperidine.]
[C04AX02, phenoxybenzamine, The risk or severity of adverse effects can be increased when Baclofen is combined with Phenoxybenzamine.]
[V03AB36, phentolamine, The risk or severity of adverse effects can be increased when Baclofen is combined with Phentolamine.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N03AB02, phenytoin, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Phenytoin.]
[S01AE05, levofloxacin, Baclofen may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Baclofen may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[C08CX01, mibefradil, The risk or severity of adverse effects can be increased when Baclofen is combined with Mibefradil.]
[N05AG02, pimozide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pimozide.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Pindolol.]
[C10AA05, atorvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Atorvastatin.]
[J01CA12, piperacillin, Baclofen may decrease the excretion rate of Piperacillin which could result in a higher serum level.]
[J05AE01, saquinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Saquinavir.]
[N05AC04, pipothiazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pipotiazine.]
[N06BX03, piracetam, Baclofen may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Baclofen is combined with Eprosartan.]
[A02BX03, pirenzepine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Piritramide.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[N02CX01, pizotyline, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[C09CA04, irbesartan, The risk or severity of adverse effects can be increased when Baclofen is combined with Irbesartan.]
[N05CA22, proxibarbal, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Proxibarbal.]
[A10BG02, rosiglitazone, The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Baclofen.]
[A03AE01, alosetron, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Alosetron.]
[C03AA05, polythiazide, The risk or severity of adverse effects can be increased when Baclofen is combined with Polythiazide.]
[J05AE03, ritonavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ritonavir.]
[A10BH03, saxagliptin, The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Baclofen.]
[B05XA01, potassium chloride, Baclofen may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Baclofen.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Pitavastatin.]
[C07AB01, practolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Practolol.]
[N05BA11, prazepam, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Prazepam.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Baclofen is combined with Prazosin.]
[H02AB07, prednisone, Baclofen may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[N01BB04, prilocaine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Prilocaine.]
[N03AA03, primidone, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Primidone.]
[M04AB01, probenecid, Baclofen may decrease the excretion rate of Probenecid which could result in a higher serum level.]
[C01BA02, procainamide, Baclofen may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of hypotension can be increased when Baclofen is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of hypotension can be increased when Baclofen is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Fenofibrate.]
[N05AB04, prochlorperazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Prochlorperazine.]
[N04AA04, procyclidine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[N05AA03, promazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Promazine.]
[R06AD02, promethazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Promethazine.]
[N01AX04, propanidid, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Propanidid.]
[A03AB05, propantheline, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Periciazine.]
[N05CM06, propiomazine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[N01AX10, propofol, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Propofol.]
[N02AC04, propoxyphene, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dextropropoxyphene.]
[C07AA05, propranolol, The risk or severity of adverse effects can be increased when Baclofen is combined with Propranolol.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Propylthiouracil.]
[N02CC04, rizatriptan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Rizatriptan.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Baclofen is combined with Epoprostenol.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Montelukast.]
[N06AA11, protriptyline, The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Protriptyline.]
[N05AX12, aripiprazole, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.]
[N07XX07, dalfampridine, Baclofen may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[A03AB15, diphemanil, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Talbutal.]
[N05CA09, vinbarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vinbarbital.]
[N05BB02, captodiamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Captodiame.]
[M03BA04, styramate, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Styramate.]
[P02CC01, pyrantel, The therapeutic efficacy of Pyrantel can be increased when used in combination with Baclofen.]
[J04AK01, pyrazinamide, Baclofen may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[R06AC01, pyrilamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mepyramine.]
[C01BA01, quinidine, Baclofen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The therapeutic efficacy of Quinine can be decreased when used in combination with Baclofen.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ranitidine.]
[C02AA01, rescinnamine, The risk or severity of adverse effects can be increased when Baclofen is combined with Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Baclofen is combined with Reserpine.]
[J05AP01, ribavirin, Baclofen may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[N06AX01, 5-hydroxytryptophan, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01FA02, scopolamine, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Secobarbital.]
[N04BD01, selegiline, The risk or severity of hypotension can be increased when Baclofen is combined with Selegiline.]
[J01GB08, sisomicin, Sisomicin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A12CD01, sodium fluoride, Baclofen may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Baclofen may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AG01, valproic acid, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Valproic acid.]
